Literature DB >> 4039943

Refractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporine.

P R Kelsey, K P Schofield, C G Geary.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4039943     DOI： 10.1111/j.1365-2141.1985.tb07400.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Current concepts in the treatment of immune thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

2.  Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.

Authors:  Y Novik; L Oleksowicz; P H Wiernik
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Authors:  Ara Metjian; Charles S Abrams
Journal:  Biologics       Date:  2009-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.